Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age)
2020-07-04
عنوان الدراسة
Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age)
داعم الدراسة
Gsk
دواء الدراسة
Meningococcal ACWY Conjugate Vaccine
رقم بروتوكول الدراسة
107402
حالة الدراسة
Completed
موقع الدراسة
King Abdulaziz Medical City NG (Riyadh)
مرحلة الدراسة
3b
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。